77.3%
chimeric antigen receptor (CAR)-T therapymultiple myelomasubtoxic osalmid
…ntigen escape is one of the leading causes of relapse following chimeric antigen receptor (CAR)-T therapy, particularly in multiple myeloma. A critical gap persists in u…